Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrorelix pamoate intermittent IM dosing in symptomatic BPH
2007-003414-34Phase 3Terminated
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Aug 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in benign prostatic hyperplasia (BPH) comparing Cetrorelix pamoate arm with Placebo arm (2 arms). Started Aug 2007; status: terminated.
02
Drugs
cetrorelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2007-003414-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003414-34.